BRADENTON, Fla., Oct. 28 /CNW/ -- WellSpring Pharmaceutical Corporation,
a growing North American-based pharmaceutical manufacturer, today announced
that Wendy Shusko has been named Chief Operating Officer. Formerly, Ms.
Shusko held the position of Chief Financial Officer, having joined the company
in early 2000. In her new role as COO, Ms. Shusko will maintain financial
responsibilities while broadening her areas of oversight to operations with an
initial focus on the newly acquired consumer brands product line.
"WellSpring has been successful in the relaunch of older niche
prescription products. We now have the opportunity to show equal success with
our new niche consumer products portfolio," said Ms. Shusko. "I am looking
forward to the challenge and am pleased to be able to take part in
WellSpring's continued growth."
Ms. Shusko has over twenty years' experience of combined financial and
operational experience with sixteen of those years in the pharmaceutical
industry. From 1992 until joining the WellSpring team, Ms. Shusko worked in
various management and financial capacities for Roberts Pharmaceutical
Corporation, an international, multi-faceted pharmaceutical company, including
Director of Finance and Financial Operations.
"WellSpring's success thus far can be attributed to driven efforts toward
a common vision. I am now asking Ms. Shusko to apply her experience and
skills to operations with the anticipation that we will continue that trend in
the years to come," said Dr. Robert A. Vukovich, WellSpring's CEO and
About the Company
WellSpring Pharmaceutical Corp has made the development, marketing and
sales of new and novel prescription and OTC drug products its strategic focus.
WellSpring's prescription drug products include Dyrenium (R) (diuretic) and
Dibenzyline (R) (anti-hypertension) which are marketed in the US. The firm is
an active acquirer of pharmaceutical brands and enhances their value through
the development of product improvements and line extensions.
WellSpring is a privately held pharmaceutical company founded in 1999 by
Dr. Robert A. Vukovich, the firm's CEO and Chairman. Dr. Vukovich previously
founded and managed Roberts Pharmaceutical Corporation of Eatontown, NJ until
its acquisition by Shire Pharmaceutical Group in 1999. WellSpring owns and
operates an FDA approved manufacturing plant in Oakville, Ontario, Canada. Its
administrative headquarters are located in Bradenton, Florida. The firm
provides contract manufacturing services to the pharmaceutical industry and
manufactures prescription and OTC drug products for both the US and Canada.
Contact: Dr. Robert A. Vukovich, +1-941-552-7880, or +1-941-504-1229, or
Wendy Shusko, +1-941-552-7881.
WellSpring Websites: www.wellspringpharm.com, www.wpcoutsourcing.com,
For further information:
For further information: Dr. Robert A. Vukovich, +1-941-552-7880,
+1-941-504-1229, or Wendy Shusko, +1-941-552-7881, both for WellSpring
Pharmaceutical Corporation Web Site: http://www.wellspringpharm.com